BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37804880)

  • 21. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
    Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
    Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets.
    Baghbani F; Moztarzadeh F
    Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable magnetic nanofibers with ON-OFF switchable release of curcumin for possible local hyperthermic chemotherapy of melanoma.
    Wei W; Zarghami N; Abasi M; Ertas YN; Pilehvar Y
    J Biomed Mater Res A; 2022 Apr; 110(4):851-860. PubMed ID: 34786813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual responsive magnetic composite nanogels for thermo-chemotherapy.
    Indulekha S; Arunkumar P; Bahadur D; Srivastava R
    Colloids Surf B Biointerfaces; 2017 Jul; 155():304-313. PubMed ID: 28448900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy.
    Ma W; Guo Q; Li Y; Wang X; Wang J; Tu P
    Eur J Pharm Biopharm; 2017 Mar; 112():209-223. PubMed ID: 27913127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
    Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
    Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The comparative effect of wrapping solid gold nanoparticles and hollow gold nanoparticles with doxorubicin-loaded thermosensitive liposomes for cancer thermo-chemotherapy.
    Li Y; He D; Tu J; Wang R; Zu C; Chen Y; Yang W; Shi D; Webster TJ; Shen Y
    Nanoscale; 2018 May; 10(18):8628-8641. PubMed ID: 29697100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced doxorubicin delivery and cytotoxicity in multidrug resistant cancer cells using multifunctional magnetic nanoparticles.
    Pilapong C; Keereeta Y; Munkhetkorn S; Thongtem S; Thongtem T
    Colloids Surf B Biointerfaces; 2014 Jan; 113():249-53. PubMed ID: 24103503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer.
    Lv L; Liu C; Chen C; Yu X; Chen G; Shi Y; Qin F; Ou J; Qiu K; Li G
    Oncotarget; 2016 May; 7(22):32184-99. PubMed ID: 27058756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Modular Coassembly Approach to All-In-One Multifunctional Nanoplatform for Synergistic Codelivery of Doxorubicin and Curcumin.
    Yang M; Yu L; Guo R; Dong A; Lin C; Zhang J
    Nanomaterials (Basel); 2018 Mar; 8(3):. PubMed ID: 29543780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicity Reduction and Efficacy Promotion of Doxorubicin in the Treatment of Breast Tumors Assisted by Enhanced Oral Absorption of Curcumin-Loaded Lipid-Polyester Mixed Nanoparticles.
    Wang N; Zhang Y; Liu H; Wang A; Ren T; Gou J; Zhang Y; Yin T; He H; Tang X
    Mol Pharm; 2020 Dec; 17(12):4533-4547. PubMed ID: 33201717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
    Wang L; Wang W; Rui Z; Zhou D
    Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional nanoparticles improve therapeutic effect for breast cancer by simultaneously antagonizing multiple mechanisms of multidrug resistance.
    Yin Q; Shen J; Zhang Z; Yu H; Chen L; Gu W; Li Y
    Biomacromolecules; 2013 Jul; 14(7):2242-52. PubMed ID: 23682680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy.
    Yao X; Niu X; Ma K; Huang P; Grothe J; Kaskel S; Zhu Y
    Small; 2017 Jan; 13(2):. PubMed ID: 27735129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MOF-derived novel porous Fe
    Xiang Z; Qi Y; Lu Y; Hu Z; Wang X; Jia W; Hu J; Ji J; Lu W
    J Mater Chem B; 2020 Sep; 8(37):8671-8683. PubMed ID: 32856668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
    Vakilinezhad MA; Amini A; Dara T; Alipour S
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid Mesoporous-Microporous Nanocarriers for Overcoming Multidrug Resistance by Sequential Drug Delivery.
    Wang L; Guan H; Wang Z; Xing Y; Zhang J; Cai K
    Mol Pharm; 2018 Jul; 15(7):2503-2512. PubMed ID: 29768014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.